Researchers in Imperial’s Institute of Biomedical Engineering, led by Professor Chris Toumazou, are doing pioneering work leading to new developments in medical diagnosis equipment, personalised healthcare devices, new regenerative medicine techniques and new medical imaging technologies.
- Imperial and its spinout company DNA Electronics have developed SNP Dr, a prototype healthcare device that assesses whether patients are genetically predisposed to suffering adverse reactions to prescription drugs.
- Professor Toumazou has also played a key role in developing the first cochlear implant, which can improve hearing in people who are profoundly deaf or very hard of hearing, and has received international recognition for his work.
